Discontinued — last reported Q1 '11
Thermo Fisher Scientific Restructuring Reserve increased by 14.9% to $85.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 60.4%, from $53.00M to $85.00M. Over 4 years (FY 2020 to FY 2024), Restructuring Reserve shows an upward trend with a 24.2% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
A high reserve indicates significant ongoing restructuring, which may signal operational inefficiency or a strategic pivot.
This represents the estimated liability for costs associated with formal restructuring plans, such as workforce reductio...
Used to evaluate the scale of operational transformation efforts compared to industry peers.
restructuring_reserve| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $13.00M | $12.00M | $17.00M | $12.00M | $15.00M | $17.00M | $41.00M | $55.00M | $98.00M | $73.00M | $60.00M | $51.00M | $49.00M | $53.00M | $50.00M | $59.00M | $74.00M | $85.00M |
| QoQ Change | — | -7.7% | +41.7% | -29.4% | +25.0% | +13.3% | +141.2% | +34.1% | +78.2% | -25.5% | -17.8% | -15.0% | -3.9% | +8.2% | -5.7% | +18.0% | +25.4% | +14.9% |
| YoY Change | — | — | — | — | +15.4% | +41.7% | +141.2% | +358.3% | +553.3% | +329.4% | +46.3% | -7.3% | -50.0% | -27.4% | -16.7% | +15.7% | +51.0% | +60.4% |
We use cookies for analytics. See our Privacy and Cookie Policy.